PaxMedica, Inc. (PXMD)
OTCMKTS · Delayed Price · Currency is USD
0.0005
0.00 (0.00%)
Jul 29, 2026, 4:00 PM EST
PaxMedica Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Cash & Equivalents | 0.44 | 4.71 | 1.9 | 0.44 | 1.12 | 0.02 |
Cash & Short-Term Investments | 0.44 | 4.71 | 1.9 | 0.44 | 1.12 | 0.02 |
Cash Growth | -61.42% | 147.68% | 328.27% | -60.48% | 4404.05% | 167.61% |
Prepaid Expenses | -0.02 | 0.97 | 0.3 | - | - | - |
Total Current Assets | 0.82 | 5.68 | 2.2 | 0.44 | 1.12 | 0.02 |
Long-Term Deferred Charges | - | - | - | 0.2 | - | - |
Total Assets | 0.82 | 5.68 | 2.2 | 0.65 | 1.12 | 0.02 |
Liabilities
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Accounts Payable | 2.15 | 0.83 | 0.74 | 0.74 | 0.38 | 0.05 |
Accrued Expenses | 0.11 | 0.97 | 1.02 | 0.68 | 0.7 | 0.08 |
Short-Term Debt | - | - | 0.17 | - | 0.61 | - |
Other Current Liabilities | - | - | 0.16 | 9.34 | 4.06 | - |
Total Current Liabilities | 2.25 | 1.8 | 2.1 | 10.76 | 5.75 | 0.12 |
Long-Term Unearned Revenue | 0.5 | 0.5 | - | - | - | - |
Total Liabilities | 2.75 | 2.3 | 2.1 | 10.76 | 5.75 | 0.12 |
Shareholders' Equity
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Common Stock | 0 | 0 | 0 | 0 | 0 | - |
Additional Paid-In Capital | 57.66 | 55.41 | 33.85 | 8.83 | 4.08 | - |
Retained Earnings | -59.6 | -52.03 | -33.74 | -18.94 | -8.71 | -0.86 |
Total Common Equity | -1.93 | 3.39 | 0.11 | -10.11 | -4.63 | -0.86 |
Shareholders' Equity | -1.93 | 3.39 | 0.11 | -10.11 | -4.63 | -0.1 |
Total Liabilities & Equity | 0.82 | 5.68 | 2.2 | 0.65 | 1.12 | 0.02 |
Additional Metrics
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Total Debt | - | - | 0.17 | - | 0.61 | - |
Net Cash (Debt) | 0.44 | 4.71 | 1.73 | 0.44 | 0.51 | 0.02 |
Net Cash Growth | - | 172.55% | 289.19% | -13.26% | 1952.29% | 167.61% |
Net Cash Per Share | 0.06 | 2.83 | 3.36 | 1.13 | 1.51 | 0.07 |
Filing Date Shares Outstanding | 126.26 | 7.41 | 0.8 | 0.41 | 0.34 | 5.78 |
Total Common Shares Outstanding | 10.88 | 7.4 | 0.71 | 0.41 | 0.34 | 5.78 |
Working Capital | -1.43 | 3.89 | 0.11 | -10.31 | -4.63 | -0.1 |
Book Value Per Share | -0.18 | 0.46 | 0.15 | -24.86 | -13.62 | -0.15 |
Tangible Book Value | -1.93 | 3.39 | 0.11 | -10.11 | -4.63 | -0.86 |
Tangible Book Value Per Share | -0.18 | 0.46 | 0.15 | -24.86 | -13.62 | -0.15 |